scispace - formally typeset
M

Mónica L. Fanarraga

Researcher at University of Cantabria

Publications -  36
Citations -  685

Mónica L. Fanarraga is an academic researcher from University of Cantabria. The author has contributed to research in topics: Microtubule & Tubulin. The author has an hindex of 13, co-authored 36 publications receiving 525 citations.

Papers
More filters
Journal ArticleDOI

Expression of unphosphorylated class III beta-tubulin isotype in neuroepithelial cells demonstrates neuroblast commitment and differentiation.

TL;DR: U‐β6 is an earlier marker than TuJ‐1 for the neuronal lineage in vivo, and it is thus the earliest neuronal lineage marker known so far, correlating with a drop in unphosphorylated class‐III β‐tubulin immunostaining levels.
Journal ArticleDOI

Multiwalled carbon nanotubes display microtubule biomimetic properties in vivo, enhancing microtubule assembly and stabilization.

TL;DR: This work demonstrates in vivo how multiwalled carbon nanotubes (MWCNTs) interact with microtubules in human cancer cells (HeLa) blocking mitosis and leading to cell death by apoptosis and suggests that, inside the cells, MWCNTs display microtubule biomimetic properties.
Journal ArticleDOI

Multiwalled Carbon Nanotubes Inhibit Tumor Progression in a Mouse Model.

TL;DR: Interestingly, the MWCNT anti‐tumoral effects are maintained even in solid melanomas generated from paclitaxel‐resistant cells, providing great expectation in the development of groundbreaking adjuvant synthetic microtubule‐stabilizing chemotherapies to overcome drug resistance in cancer.
Journal ArticleDOI

Inhibition of Cancer Cell Migration by Multiwalled Carbon Nanotubes

TL;DR: It is shown MWCNTs disrupt the centrosomal microtubule cytoskeletal organization triggering potent antimigratory effects in different cancer cells.
Journal ArticleDOI

Cellular vaccines in listeriosis: role of the Listeria antigen GAPDH

TL;DR: This is believed to be the first study to explore the use of a novel GAPDH antigen as a potential DC-based vaccine candidate for listeriosis, whose efficiency appears to highlight the relevance of vaccine designs containing multiple CD4+ and CD8+ epitopes.